About
Drug reformulation
Areas of Focus
Categories
Generic DrugDrug Delivery & Formulation
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
856
By Phase
PHASE3: 1PHASE2: 2
By Status
UNKNOWN: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05041010Lead Sponsor
Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
PHASE3Unknown
496 participants
Started: Dec 25, 2021 · Completed: Jan 31, 2025
NCT03651557Lead Sponsor
Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients
PHASE2Unknown
150 participants
Started: Nov 29, 2018 · Completed: May 31, 2021
NCT02831088Lead Sponsor
Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC)
PHASE2Unknown
210 participants
Started: Jul 31, 2016 · Completed: Dec 30, 2018
Locations (1)
Headquarters
Derbyshire, UK
Map
Loading map...